Chemical Formula: C9H13N3O4

Chemical Formula C9H13N3O4

Found 30 metabolite its formula value is C9H13N3O4

Deoxycytidine

4-Amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one

C9H13N3O4 (227.0906018)


Deoxycytidine, also known as dC, belongs to the class of organic compounds known as pyrimidine 2-deoxyribonucleosides. Pyrimidine 2-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. Deoxycytidine is also classified as a deoxyribonucleoside, a component of deoxyribonucleic acid (DNA). Deoxycytidine is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the 2 position. Deoxycytidine exists in all living species, ranging from bacteria to plants to humans. Degradation of DNA through apoptosis or cell death produces deoxycytidine. Within humans, deoxycytidine participates in a number of enzymatic reactions. In particular, deoxycytidine can be biosynthesized from dCMP through the action of the enzyme cytosolic purine 5-nucleotidase. In addition, deoxycytidine can be converted into dCMP; which is mediated by the enzyme uridine-cytidine kinase-like 1. Deoxycytidine can be phosphorylated at the C-5 position by the enzyme deoxycytidine kinase to produce deoxycytidine monophosphate (dCMP), and to a lesser extent, deoxycytidine diphosphate (dCDP), and deoxycytidine triphosphate (dCTP). Deoxycytidine can also be phosphorylated by thymidine kinase 2 (TK2). Deoxycytidine can potentially be used for the treatment of the metabolic disorder known as thymidine kinase 2 deficiency (TK2 deficiency). TK2 deficiency has three disease subtypes: i) infantile-onset myopathy with rapid progression to early death ii) childhood-onset myopathy, which resembles spinal muscular atrophy (SMA) type III, begins between ages 1 and 12 years with progression to loss of ambulation within few years and iii) late-onset myopathy starting at age 12 year or later with moderate to severe myopathy manifesting as either isolated chronic progressive external ophthalmoplegia (CPEO) or a generalized myopathy with CPEO plus facial and limb weakness, gradual progression, and, in some cases, respiratory failure and loss of ability to walk in adulthood (PMID: 28318037). In mouse models of TK2, dC was shown to delay disease onset, prolong life span and restore mtDNA copy number as well as respiratory chain enzyme activities (PMID: 28318037). One of the principal nucleosides of DNA composed of cytosine and deoxyribose. A nucleoside consists of only a pentose sugar linked to a purine or pyrimidine base, without a phosphate group. When N1 is linked to the C1 of deoxyribose, deoxynucleosides and nucleotides are formed from cytosine and deoxyribose; deoxycytidine monophosphate (dCMP), deoxycytidine diphosphate (dCDP), deoxycytidine triphosphate (dCTP). CTP is the source of the cytidine in RNA (ribonucleic acid) and deoxycytidine triphosphate (dCTP) is the source of the deoxycytidine in DNA (deoxyribonucleic acid). [HMDB]. Deoxycytidine is found in many foods, some of which are japanese pumpkin, turmeric, prairie turnip, and kai-lan. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Acquisition and generation of the data is financially supported in part by CREST/JST. C26170 - Protective Agent > C2459 - Chemoprotective Agent COVID info from COVID-19 Disease Map KEIO_ID D055; [MS2] KO008940 Corona-virus KEIO_ID D055 Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS 2'-Deoxycytidine, a deoxyribonucleoside, can inhibit biological effects of Bromodeoxyuridine (Brdu). 2'-Deoxycytidine is essential for the synthesis of nucleic acids, that can be used for the research of cancer[1][2]. 2'-Deoxycytidine, a deoxyribonucleoside, could inhibit biological effects of Bromodeoxyuridine (Brdu).

   

Torcitabine

Torcitabine

C9H13N3O4 (227.0906018)


C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent Torcitabine (2'-Deoxy-L-cytidine) is an antiviral agent. Torcitabine has the potential for chronic hepatitis B virus infection treatment[1][2].

   

Cytosine deoxyribonucleoside

4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

C9H13N3O4 (227.0906018)


1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-1,4-dihydropyrimidin-2-ol belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. 1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-1,4-dihydropyrimidin-2-ol is an extremely weak basic (essentially neutral) compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). Cytosine deoxyribonucleoside is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Cytosine deoxyribonucleoside is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. Cytosine deoxyribonucleoside, commonly referred to as deoxycytidine, is a nucleoside consisting of deoxyribose (a sugar) and cytosine (a nitrogenous base). It is an essential component of DNA and plays several critical roles in biological systems. Here is a detailed description of its biological functions: DNA Synthesis: Deoxycytidine is a key building block for the synthesis of DNA. During DNA replication, deoxycytidine is incorporated into the growing DNA strand as deoxycytidine monophosphate (dCMP), which is then converted to deoxycytidine triphosphate (dCTP) by cellular kinases. dCTP serves as a substrate for DNA polymerase, which adds deoxycytidine to the nascent DNA strand according to the base-pairing rule (cytosine pairs with guanine). DNA Repair: Deoxycytidine is involved in the DNA repair process. When DNA is damaged by environmental factors or errors during replication, repair mechanisms such as base excision repair, nucleotide excision repair, and mismatch repair utilize deoxycytidine to correct the lesions and restore the DNA to its original sequence. Genetic Coding: As part of the DNA molecule, deoxycytidine contributes to the genetic code. The sequence of nucleotides, including deoxycytidine, in DNA determines the sequence of amino acids in proteins, which ultimately dictates the structure and function of proteins and, consequently, the phenotype of the organism. Gene Expression: Deoxycytidine is also involved in gene expression. The presence of cytosine in specific sequences can lead to the formation of methyl groups (DNA methylation), which can regulate gene expression by either promoting or repressing the transcription of genes. Antiviral and Anticancer Therapy: Deoxycytidine analogs, such as cytarabine (ara-C) and zidovudine (AZT), are used in antiviral and anticancer therapies. These analogs can be incorporated into the viral or cancer cell DNA, leading to chain termination or other disruptions in DNA synthesis and function. Cellular Metabolism: Deoxycytidine can be phosphorylated to form deoxycytidine monophosphate (dCMP), deoxycytidine diphosphate (dCDP), and deoxycytidine triphosphate (dCTP). These phosphorylated forms are intermediates in the metabolic pathways of nucleotide synthesis and can be used for energy transfer within the cell. Nucleotide Pool Homeostasis: Deoxycytidine is part of the deoxynucleotide pool within the cell. Maintaining a balance of deoxynucleotides is crucial for various cellular processes, including DNA synthesis, repair, and regulation of gene expression. Enzymes such as nucleotide kinases, nucleotide phosphatases, and nucleoside transporters help regulate the levels of deoxycytidine and its phosphorylated forms.

   

2-Nitro-alpha-((1-propenyloxy)methyl)imidazole-1-ethanol

1-(2-nitro-1H-imidazol-1-yl)-3-(prop-1-en-1-yloxy)propan-2-ol

C9H13N3O4 (227.0906018)


   

4-amino-1-(3,5-dihydroxy-tetrahydro-pyran-2-yl)-1H-pyrimidin-2-one|Pentopyranin

4-amino-1-(3,5-dihydroxy-tetrahydro-pyran-2-yl)-1H-pyrimidin-2-one|Pentopyranin

C9H13N3O4 (227.0906018)


   

2-Deoxycytidine

2-Deoxycytidine monohydrate

C9H13N3O4 (227.0906018)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite A pyrimidine 2-deoxyribonucleoside having cytosine as the nucleobase. C26170 - Protective Agent > C2459 - Chemoprotective Agent COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 2'-Deoxycytidine, a deoxyribonucleoside, can inhibit biological effects of Bromodeoxyuridine (Brdu). 2'-Deoxycytidine is essential for the synthesis of nucleic acids, that can be used for the research of cancer[1][2]. 2'-Deoxycytidine, a deoxyribonucleoside, could inhibit biological effects of Bromodeoxyuridine (Brdu).

   

Deoxycytidine

2-Deoxycytidine monohydrate

C9H13N3O4 (227.0906018)


2'-Deoxycytidine, a deoxyribonucleoside, can inhibit biological effects of Bromodeoxyuridine (Brdu). 2'-Deoxycytidine is essential for the synthesis of nucleic acids, that can be used for the research of cancer[1][2]. 2'-Deoxycytidine, a deoxyribonucleoside, could inhibit biological effects of Bromodeoxyuridine (Brdu).

   

Deoxycytidine; LC-tDDA; CE10

Deoxycytidine; LC-tDDA; CE10

C9H13N3O4 (227.0906018)


   

Deoxycytidine; LC-tDDA; CE20

Deoxycytidine; LC-tDDA; CE20

C9H13N3O4 (227.0906018)


   

Deoxycytidine; LC-tDDA; CE30

Deoxycytidine; LC-tDDA; CE30

C9H13N3O4 (227.0906018)


   

Deoxycytidine; LC-tDDA; CE40

Deoxycytidine; LC-tDDA; CE40

C9H13N3O4 (227.0906018)


   

Deoxycytidine; AIF; CE0; CorrDec

Deoxycytidine; AIF; CE0; CorrDec

C9H13N3O4 (227.0906018)


   

Deoxycytidine; AIF; CE10; MS2Dec

Deoxycytidine; AIF; CE10; MS2Dec

C9H13N3O4 (227.0906018)


   

Deoxycytidine; AIF; CE30; MS2Dec

Deoxycytidine; AIF; CE30; MS2Dec

C9H13N3O4 (227.0906018)


   

Deoxycytidine; AIF; CE10; CorrDec

Deoxycytidine; AIF; CE10; CorrDec

C9H13N3O4 (227.0906018)


   

Deoxycytidine; AIF; CE30; CorrDec

Deoxycytidine; AIF; CE30; CorrDec

C9H13N3O4 (227.0906018)


   

Deoxycytidine dimer; AIF; CE10; MS2Dec

Deoxycytidine dimer; AIF; CE10; MS2Dec

C9H13N3O4 (227.0906018)


   

Deoxycytidine dimer; AIF; CE30; MS2Dec

Deoxycytidine dimer; AIF; CE30; MS2Dec

C9H13N3O4 (227.0906018)


   

Deoxycytidine; AIF; CE0; MS2Dec

Deoxycytidine; AIF; CE0; MS2Dec

C9H13N3O4 (227.0906018)


   

Deoxycytidine dimer; AIF; CE0; MS2Dec

Deoxycytidine dimer; AIF; CE0; MS2Dec

C9H13N3O4 (227.0906018)


   

3-Deoxycytidine

3-Deoxycytidine

C9H13N3O4 (227.0906018)


4-Amino-1-((2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one (3'-Deoxycytidine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

1-ethyl-3-methyl-4-nitro-1h-pyrazole-5-carboxylic acid ethyl ester

1-ethyl-3-methyl-4-nitro-1h-pyrazole-5-carboxylic acid ethyl ester

C9H13N3O4 (227.0906018)


   

3-amino-2,3-dideoxyuridine

3-amino-2,3-dideoxyuridine

C9H13N3O4 (227.0906018)


   

2-ethyl-4-nitro-5-propylpyrazole-3-carboxylic acid

2-ethyl-4-nitro-5-propylpyrazole-3-carboxylic acid

C9H13N3O4 (227.0906018)


   

3-ETHYL-1-METHYL-4-NITRO-1H-PYRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

3-ETHYL-1-METHYL-4-NITRO-1H-PYRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

C9H13N3O4 (227.0906018)


   

ethyl (3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)acetate

ethyl (3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)acetate

C9H13N3O4 (227.0906018)


   

diethyl 4-amino-1H-imidazole-2,5-dicarboxylate

diethyl 4-amino-1H-imidazole-2,5-dicarboxylate

C9H13N3O4 (227.0906018)


   

2-Nitro-alpha-((1-propenyloxy)methyl)imidazole-1-ethanol

2-Nitro-alpha-((1-propenyloxy)methyl)imidazole-1-ethanol

C9H13N3O4 (227.0906018)


   

4-(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)butanoic acid

4-(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)butanoic acid

C9H13N3O4 (227.0906018)


   

N-Lactoyl histidine

N-Lactoyl histidine

C9H13N3O4 (227.0906018)